Stock Research for ALPMF

ALPMF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALPMF Stock Chart & Research Data

The ALPMF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALPMF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALPMF Due diligence Resources & Stock Charts

The ALPMF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALPMF Detailed Price Forecast - CNN Money CNN View ALPMF Detailed Summary - Google Finance
Yahoo View ALPMF Detailed Summary - Yahoo! Finance Zacks View ALPMF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALPMF Trends & Analysis - Trade-Ideas Barrons View ALPMF Major Holders - Barrons
NASDAQ View ALPMF Call Transcripts - NASDAQ Seeking View ALPMF Breaking News & Analysis - Seeking Alpha
Spotlight View ALPMF Annual Report - CompanySpotlight.com OTC Report View ALPMF OTC Short Report - OTCShortReport.com
TradeKing View ALPMF Fundamentals - TradeKing Charts View ALPMF SEC Filings - Bar Chart
WSJ View Historical Prices for ALPMF - The WSJ Morningstar View Performance/Total Return for ALPMF - Morningstar
MarketWatch View the Analyst Estimates for ALPMF - MarketWatch CNBC View the Earnings History for ALPMF - CNBC
StockMarketWatch View the ALPMF Earnings - StockMarketWatch MacroAxis View ALPMF Buy or Sell Recommendations - MacroAxis
Bullish View the ALPMF Bullish Patterns - American Bulls Short Pains View ALPMF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALPMF Stock Mentions - StockTwits PennyStocks View ALPMF Stock Mentions - PennyStockTweets
Twitter View ALPMF Stock Mentions - Twitter Invest Hub View ALPMF Investment Forum News - Investor Hub
Yahoo View ALPMF Stock Mentions - Yahoo! Message Board Seeking Alpha View ALPMF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALPMF - SECform4.com Insider Cow View Insider Transactions for ALPMF - Insider Cow
CNBC View ALPMF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALPMF - OTC Markets
Yahoo View Insider Transactions for ALPMF - Yahoo! Finance NASDAQ View Institutional Holdings for ALPMF - NASDAQ


Stock Charts

FinViz View ALPMF Stock Insight & Charts - FinViz.com StockCharts View ALPMF Investment Charts - StockCharts.com
BarChart View ALPMF Stock Overview & Charts - BarChart Trading View View ALPMF User Generated Charts - Trading View




Latest Financial News for ALPMF


Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Posted on Tuesday April 23, 2024

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a label extension for XTANDI™ (enzalutamide) as monotherapy or in combination with androgen deprivation therapy (ADT) for the treatment of adult men with high-risk biochemical recurrent (BCR) non-metastatic hormone-sensitive prostate cancer (nmHSPC) who are unsuitable for salvage-radiotherapy.


Pharmas form joint venture to jumpstart Japanese drug research
Posted on Monday April 22, 2024

A new initiative backed by Takeda, Astellas and Sumitomo Mitsui Banking aims to combat a decade-long decline in drug R&D productivity in Japan.


Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Posted on Monday April 22, 2024

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK, President and CEO; Christophe Weber, "Takeda"), Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), and Sumitomo Mitsui Banking Corporation (President & CEO: Akihiro Fukutome, "SMBC") today announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company. The new company will be dedicated to the incubation*1 of early drug discovery programs, primarily origin


U.S. Stocks Erase Early Gains
Posted on Monday April 15, 2024

U.S. stocks extended recent declines as March retail sales increased more than expected, causing traders scale back bets on Fed rate cuts.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.